20031002
 Health Care Brief -- Bayer AG: Plasma Business Will Be Sold   The Wall Street Journal,  Oct 3, 2003  Bayer AG said it plans to sell its North Carolina-based plasma business. A Bayer spokesman said the German pharmaceuticals company hasn't begun talks with potential buyers. Among the plasma business's products is Gamunex, a drug recently approved for sale in the U.S. and Canada.   
